Reports

Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Fibromyalgia Treatment Market Share, Size, Trends, Analysis, Growth, Forecast: By Drug Class: Antidepressants, Antiepileptic, Muscle Relaxants, Analgesics, Others; By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others; Regional Analysis; Market Dynamics: SWOT Analysis; Competitive Landscape; 2023-2028

Global Fibromyalgia Treatment Market Outlook

The global fibromyalgia treatment market size attained a value of USD 2612.68 million in 2022. The market is further expected to grow at a CAGR of 8.10% between 2023 and 2028, to reach a value of USD 4169.08 million by 2028.

 

Key Trends in the Market

Fibromyalgia is defined as a musculoskeletal disorder which causes intense pain, fatigue, sleep, mood swings, headache, depression, and memory issues. This disorder increases the pain sensations to the brain and spinal cord. As there is no definitive cure, fibromyalgia treatment is aimed at providing comfort to the patients using medications and specialised drugs. Women are more susceptible to fibromyalgia.  

 

  • The increasing prevalence of fibromyalgia, triggered by the sedentary lifestyles led by the working population, genetic predisposition, infections, and traumatic events in lives of people worldwide, is fuelling the fibromyalgia treatment market growth.
  • Rising incidences of conditions such as lupus, rheumatoid arthritis, and osteoarthritis are leading to an increase in the number of cases of fibromyalgia, as patients with these conditions are more likely to develop fibromyalgia at some point in their lives.
  • Over the forecast period, the anticipated increase in healthcare expenditure across the emerging economies, rising standards of living, and favourable policies of various governments are expected to improve the diagnosis and treatment infrastructure across the healthcare units, increasing the fibromyalgia treatment market size.

 

Market Analysis

Based on drug class, the market is segmented into antidepressants, antiepileptic, muscle relaxants, and analgesics, among others. On the basis of distribution channel, the market is classified into hospital pharmacy, retail pharmacy, and online pharmacy, among others. The regional markets for fibromyalgia treatment can be divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.  

 

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global fibromyalgia treatment market, covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.

 

  • Pfizer, Inc.
  • Eli Lilly and Company
  • Novartis AG
  • Allergan plc
  • Sun Pharmaceutical Industries Ltd
  • Intec Pharma Ltd
  • Astellas Pharma Inc
  • Prismic Pharmaceuticals, Inc.
  • Others

 

Market Share by Drug Class

The antidepressant segment, based on drug class, accounts for a sizable fibromyalgia treatment market share. Antidepressants are an effective medication which reduces severe depression and feelings of trauma or exhaustion, while preventing their resurgence. Antidepressants are recommended by many doctors or pharmacists as they are safe and well-researched. In addition, these medicines can improve the quality of life by providing energy to carry out various day to day activities, which is expected to contribute to the fibromyalgia treatment market price. Meanwhile, the muscle relaxants segment is expected to witness a steady growth in the forecast period as it helps patients cope with muscle stress and tension. 

 

Market Share by Distribution Channel

As per the fibromyalgia treatment market report, the retail pharmacy segment accounts for a significant share of the market, based on distribution channel. This can be attributed to wider network and easier accessibility of retail pharmacies. Further, retail pharmacies bring greater convenience to people as it is usually available across remote and major locations in both urban and rural areas. Meanwhile, the online pharmacy segment is expected to register a decent growth in the forecast period due to the rising purchasing power and rapid digitalisation in the pharmaceutical and healthcare sector across the emerging economies. 

 

Competitive Landscape

Pfizer, Inc. is a leading pharmaceutical and biotechnology company which produces high-quality medications for the treatment of chronic conditions. It also carries out clinical trials and vaccine development to combat lethal infections. The company was established in the year 1849 and is currently headquartered in New York, United States. 

 

Eli Lilly and Company is a major pharmaceutical company which is headquartered in Indiana in the United States. The company was established in the year 1876 and currently manufactures high-quality medicines. Segments of this company include diabetes solution centre, oncology support centre, and insulin state patient assistance programmes, among others. 

 

Novartis AG is a prominent pharmaceutical corporation which was founded in 1996 and is currently headquartered in Basel, Switzerland. The company caters to the medical demands of patients suffering from oncological, ophthalmology, and neuro conditions, among others. Novartis AG innovates in digital and scientific technologies to transform the treatment infrastructure in order to improve patient health. 

 

Other market players include Allergan plc, Sun Pharmaceutical Industries Ltd, Intec Pharma Ltd, Astellas Pharma Inc, and Prismic Pharmaceuticals, Inc., among others.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2022
Historical Period 2018-2022
Forecast Period 2023-2028
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Drug Class
  • Distribution Channel
  • Region
Breakup by Drug Class
  • Antidepressants
  • Antiepileptic
  • Muscle Relaxants
  • Analgesics
  • Others
Breakup by Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT
  • Porter's Five Forces
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • Pfizer, Inc.
  • Eli Lilly and Company
  • Novartis AG
  • Allergan plc
  • Sun Pharmaceutical Industries Ltd
  • Intec Pharma Ltd
  • Astellas Pharma Inc
  • Prismic Pharmaceuticals, Inc.
  • Others

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Market Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Fibromyalgia Treatment Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Fibromyalgia Treatment Historical Market (2018-2022) 
    8.3    Global Fibromyalgia Treatment Market Forecast (2023-2028)
    8.4    Global Fibromyalgia Treatment Market by Drug Class
        8.4.1    Antidepressants
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2018-2022)
            8.4.1.3    Forecast Trend (2023-2028)
        8.4.2    Antiepileptic
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2018-2022)
            8.4.2.3    Forecast Trend (2023-2028)
        8.4.3    Muscle Relaxants
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2018-2022)
            8.4.3.3    Forecast Trend (2023-2028)
        8.4.4    Analgesics
            8.4.4.1    Market Share
            8.4.4.2    Historical Trend (2018-2022)
            8.4.4.3    Forecast Trend (2023-2028)
        8.4.5    Others
    8.5    Global Fibromyalgia Treatment Market by Distribution Channel
        8.5.1    Hospital Pharmacy
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2018-2022)
            8.5.1.3    Forecast Trend (2023-2028)
        8.5.2    Retail Pharmacy
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2018-2022)
            8.5.2.3    Forecast Trend (2023-2028)
        8.5.3    Online Pharmacy
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2018-2022)
            8.5.3.3    Forecast Trend (2023-2028)
        8.5.4    Others
    8.6    Global Fibromyalgia Treatment Market by Region
        8.6.1    North America
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2018-2022) 
            8.6.1.3    Forecast Trend (2023-2028)
        8.6.2    Europe
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2018-2022) 
            8.6.2.3    Forecast Trend (2023-2028)
        8.6.3    Asia Pacific
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2018-2022) 
            8.6.3.3    Forecast Trend (2023-2028)
        8.6.4    Latin America
            8.6.4.1    Market Share
            8.6.4.2    Historical Trend (2018-2022) 
            8.6.4.3    Forecast Trend (2023-2028)
        8.6.5    Middle East and Africa
            8.6.5.1    Market Share
            8.6.5.2    Historical Trend (2018-2022) 
            8.6.5.3    Forecast Trend (2023-2028)
9    North America Fibromyalgia Treatment Market Analysis
    9.1    United States of America 
        9.1.1    Market Share
        9.1.2    Historical Trend (2018-2022) 
        9.1.3    Forecast Trend (2023-2028)
    9.2    Canada
        9.2.1    Market Share
        9.2.2    Historical Trend (2018-2022) 
        9.2.3    Forecast Trend (2023-2028)
10    Europe Fibromyalgia Treatment Market Analysis
    10.1    United Kingdom
        10.1.1    Market Share
        10.1.2    Historical Trend (2018-2022) 
        10.1.3    Forecast Trend (2023-2028)
    10.2    Germany
        10.2.1    Market Share
        10.2.2    Historical Trend (2018-2022) 
        10.2.3    Forecast Trend (2023-2028)
    10.3    France
        10.3.1    Market Share
        10.3.2    Historical Trend (2018-2022) 
        10.3.3    Forecast Trend (2023-2028)
    10.4    Italy
        10.4.1    Market Share
        10.4.2    Historical Trend (2018-2022) 
        10.4.3    Forecast Trend (2023-2028)
    10.5    Others
11    Asia Pacific Fibromyalgia Treatment Market Analysis
    11.1    China
        11.1.1    Market Share
        11.1.2    Historical Trend (2018-2022) 
        11.1.3    Forecast Trend (2023-2028)
    11.2    Japan
        11.2.1    Market Share
        11.2.2    Historical Trend (2018-2022) 
        11.2.3    Forecast Trend (2023-2028)
    11.3    India
        11.3.1    Market Share
        11.3.2    Historical Trend (2018-2022) 
        11.3.3    Forecast Trend (2023-2028)
    11.4    ASEAN
        11.4.1    Market Share
        11.4.2    Historical Trend (2018-2022) 
        11.4.3    Forecast Trend (2023-2028)
    11.5    Australia
        11.5.1    Market Share
        11.5.2    Historical Trend (2018-2022) 
        11.5.3    Forecast Trend (2023-2028)
    11.6    Others
12    Latin America Fibromyalgia Treatment Market Analysis
    12.1    Brazil
        12.1.1    Market Share
        12.1.2    Historical Trend (2018-2022) 
        12.1.3    Forecast Trend (2023-2028)
    12.2    Argentina
        12.2.1    Market Share
        12.2.2    Historical Trend (2018-2022) 
        12.2.3    Forecast Trend (2023-2028)
    12.3    Mexico
        12.3.1    Market Share
        12.3.2    Historical Trend (2018-2022) 
        12.3.3    Forecast Trend (2023-2028)
    12.4    Others
13    Middle East and Africa Fibromyalgia Treatment Market Analysis
    13.1    Saudi Arabia
        13.1.1    Market Share
        13.1.2    Historical Trend (2018-2022) 
        13.1.3    Forecast Trend (2023-2028)
    13.2    United Arab Emirates
        13.2.1    Market Share
        13.2.2    Historical Trend (2018-2022) 
        13.2.3    Forecast Trend (2023-2028)
    13.3    Nigeria
        13.3.1    Market Share
        13.3.2    Historical Trend (2018-2022) 
        13.3.3    Forecast Trend (2023-2028)
    13.4    South Africa
        13.4.1    Market Share
        13.4.2    Historical Trend (2018-2022) 
        13.4.3    Forecast Trend (2023-2028)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Competitive Landscape
    15.1    Market Structure
    15.2    Company Profiles
        15.2.1    Pfizer, Inc.
            15.2.1.1    Company Overview
            15.2.1.2    Product Portfolio
            15.2.1.3    Demographic Reach and Achievements
            15.2.1.4    Certifications
        15.2.2    Eli Lilly and Company
            15.2.2.1    Company Overview
            15.2.2.2    Product Portfolio
            15.2.2.3    Demographic Reach and Achievements
            15.2.2.4    Certifications
        15.2.3    Novartis AG
            15.2.3.1    Company Overview
            15.2.3.2    Product Portfolio
            15.2.3.3    Demographic Reach and Achievements
            15.2.3.4    Certifications
        15.2.4    Allergan plc
            15.2.4.1    Company Overview
            15.2.4.2    Product Portfolio
            15.2.4.3    Demographic Reach and Achievements
            15.2.4.4    Certifications
        15.2.5    Sun Pharmaceutical Industries Ltd
            15.2.5.1    Company Overview
            15.2.5.2    Product Portfolio
            15.2.5.3    Demographic Reach and Achievements
            15.2.5.4    Certifications
        15.2.6    Intec Pharma Ltd
            15.2.6.1    Company Overview
            15.2.6.2    Product Portfolio
            15.2.6.3    Demographic Reach and Achievements
            15.2.6.4    Certifications
        15.2.7    Astellas Pharma Inc 
            15.2.7.1    Company Overview
            15.2.7.2    Product Portfolio
            15.2.7.3    Demographic Reach and Achievements
            15.2.7.4    Certifications
        15.2.8    Prismic Pharmaceuticals, Inc.
            15.2.8.1    Company Overview
            15.2.8.2    Product Portfolio
            15.2.8.3    Demographic Reach and Achievements
            15.2.8.4    Certifications
        15.2.9    Others
16    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    Global Fibromyalgia Treatment Market: Key Industry Highlights, 2018 and 2022
2.    Global Fibromyalgia Treatment Historical Market: Breakup by Drug Class (USD Million), 2018-2022
3.    Global Fibromyalgia Treatment Market Forecast: Breakup by Drug Class (USD Million), 2023-2028
4.    Global Fibromyalgia Treatment Historical Market: Breakup by Distribution Channel (USD Million), 2018-2022
5.    Global Fibromyalgia Treatment Market Forecast: Breakup by Distribution Channel (USD Million), 2023-2028
6.    Global Fibromyalgia Treatment Historical Market: Breakup by Region (USD Million), 2018-2022
7.    Global Fibromyalgia Treatment Market Forecast: Breakup by Region (USD Million), 2023-2028
8.    North America Fibromyalgia Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
9.    North America Fibromyalgia Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
10.    Europe Fibromyalgia Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
11.    Europe Fibromyalgia Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
12.    Asia Pacific Fibromyalgia Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
13.    Asia Pacific Fibromyalgia Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
14.    Latin America Fibromyalgia Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
15.    Latin America Fibromyalgia Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
16.    Middle East and Africa Fibromyalgia Treatment Historical Market: Breakup by Country (USD Million), 2018-2022
17.    Middle East and Africa Fibromyalgia Treatment Market Forecast: Breakup by Country (USD Million), 2023-2028
18.    Global Fibromyalgia Treatment Market Structure

Key Questions Answered in the Report

The market reached a value of USD 2612.68 million in 2022.

The market is estimated to grow at a CAGR of 8.10% in the forecast period of 2023 and 2028.

The market is estimated to witness a healthy growth in the forecast period of 2023-2028 to reach a value of USD 4169.08 million by 2028.

The increasing prevalence of fibromyalgia, increasing women population, rising health awareness, and increasing diagnosis infrastructure across the emerging economies are the major drivers of the market.

The key trends in the market include the emerging online retail pharmacies, rising standards of living, and favourable policies of the government.

Antidepressants, antiepileptic, muscle relaxants, and analgesics, among others, are the different drug classes included in the market report.

Hospital pharmacy, retail pharmacy, and online pharmacy, among others, are the segments of the market based on distribution channels.

Family genetics, poor lifestyle, improper nutrition, certain infections, and incidences of physical and emotional trauma can lead to fibromyalgia.

Although, a complete cure for fibromyalgia is not yet available, medications and therapeutics can help reduce the symptoms of this condition.

Pfizer, Inc., Eli Lilly and Company, Novartis AG, Allergan plc, Sun Pharmaceutical Industries Ltd, Intec Pharma Ltd, Astellas Pharma Inc, and Prismic Pharmaceuticals, Inc., among others, are the key market players, according to the fibromyalgia treatment market report.

Purchase Full Report

Mini Report

$ 2199     $1799
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3199     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$ 4199     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5199     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER